2016 Fiscal Year Final Research Report
Establishment of a novel cell-based assay for detection of potential drug-induced liver injury by considering immune- and inflammatory-related factors
Project/Area Number |
15K21057
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Pharmacology in pharmacy
Medical pharmacy
|
Research Institution | Nagoya University |
Principal Investigator |
ODA Shingo 名古屋大学, 医学系研究科, 特任助教 (10725534)
|
Research Collaborator |
SHIRAI Yuji 名古屋大学, 大学院医学系研究科, 大学院生
XU Jieyu 名古屋大学, 大学院医学系研究科, 大学院生
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Keywords | 薬物性肝障害 / 薬物代謝 / in vitroアッセイ / 免疫 / 炎症 |
Outline of Final Research Achievements |
This study sought to develop a novel cell-based assay for detecting potential drug-induced liver injury (DILI) by considering drug metabolism as well as immune- and inflammatory-related factors. Human hepatoma HepaRG or HepG2 cells were treated with drugs with different clinical DILI risks. The conditioned media were subsequently used to treat human promyelocytic leukemia HL-60 cells, and the mRNA expression levels were measured. ROC-AUC was calculated to evaluate the predictive performance of each gene mRNA as a marker to assess DILI risk. The expression of IL-8 in HL-60 cells treated with conditioned media from HepaRG cells (HL-60/HepaRG) exhibited the highest ROC-AUC value of 0.758. An integrated score calculated from the levels of S100A9, IL-1beta, and IL-8 more precisely determined the DILI risks than individual gene expression did. The developed cell-based assay using immune-related gene expression would be useful for the detection of potential DILI risks.
|
Free Research Field |
医薬品安全性学
|